BNP Paribas Discount Zert HOLN 30.../ DE000PC63FB4 /
| 14/06/2024 14:20:25 | Var.+0.450 | Denaro14:51:55 | Lettera14:51:55 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
|---|---|---|---|---|---|---|---|
| 79.350EUR | +0.57% | 79.270 Quantità in denaro: 2,000 |
79.290 Quantità in lettera: 2,000 |
HOLCIM N | - CHF | 30/12/2024 | Call |
GlobeNewswire
14:45
OneMedNet Partners with Leading Clinical Trial Design and Software Company in Significant Data Licen...
GlobeNewswire
14:45
Monte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential ...
GlobeNewswire
14:39
SECU Awarded PLANSPONSOR of the Year for Its Total Retirement Offering for Employees
GlobeNewswire
14:30
SRIVARU (SVMH) Announces PRANA 2.0 Electric Motorbike will be Available to Order Online Beginning Ju...
GlobeNewswire
14:30
Golden Triangle Ventures Announces Launch of Its Freight Brokerage Division with Full Financial Supp...
GlobeNewswire
14:30
Chijet Motor Company, Inc.’s Subsidiary Entered Into Framework Cooperation Agreement with Uzbekistan...
GlobeNewswire
14:30
FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennov...
GlobeNewswire
14:10
Diana Shipping Inc. Announces Time Charter Contract for m/v Myrsini With Cobelfret S.A.
GlobeNewswire
14:03
ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patie...
GlobeNewswire
14:00
Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
GlobeNewswire
14:00
BIO-key Introduces Passkey:YOU, a Phish-resistant, Phoneless and Tokenless Biometric FIDO Passkey Au...
GlobeNewswire
14:00
Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of ...
